Latest Capital Expenditure News

DGR Global Limited highlights a significant re-rating of its SolGold investment, driven by SolGold’s strategic staged development and updated resource estimates at the Cascabel copper-gold project in Ecuador.

SomnoMed Limited reported a robust FY25 with revenue surpassing guidance and a landmark FDA clearance for its Rest Assure® oral device, setting the stage for sustained growth in oral appliance therapy.

Alliance Aviation Services reported record FY25 revenue and flying hours but faces margin pressures from rising costs and a major contract renegotiation. The company’s refreshed leadership is focused on operational improvements and debt reduction in FY26.

Rumble Resources’ latest Scoping Study reveals a promising underground gold mining project at Western Queen South with low capital costs and strong financial returns, setting the stage for rapid development and potential resource expansion.

Axel REE Limited reveals a substantial inferred resource at its Caladão Project, advancing plans for in situ recovery trial mining in 2026 to produce rare earth and gallium products. The company’s low-cost, environmentally conscious approach positions it well within Brazil’s Lithium Valley mining hub.

DPM Metals has released a robust feasibility study for its Čoka Rakita gold project in Serbia, confirming strong economics with a $782 million net present value and a 36% internal rate of return at $1,900 per ounce gold. The study highlights increased reserves, low costs, and a clear path to production by 2029.

New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.

New Zealand King Salmon reports a $6.3 million net loss for an eight-month FY25 period, reflecting operational challenges and a shortened reporting cycle, while outlining cautious optimism for FY26 with targeted growth investments.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Beacon Minerals Limited reports a substantial 276% increase in gold resources alongside strategic exploration and development plans, setting the stage for extended mine life and shareholder returns.

Axel REE Limited reports promising metallurgical results from its Caladão Project in Brazil, confirming a magnet-rich ionic clay system with rare earth grades comparable to established Asian operations. These findings underpin a low-capital, low-operating cost in-situ leach development strategy.

Select Harvests Limited reported a robust FY2025 with a 32.4% almond price surge driving a $30.9 million NPAT increase and halving net debt. The company’s strategic investments and operational efficiencies position it well for a positive FY2026 outlook.